Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity
Document Type: Research Article
Affiliations: 1: Division of Oncological Pathology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan 2: Department of Gastroenterological Surgery, Aichi Cancer Center Central Hospital, Nagoya 464-8681, Japan 3: Department of Gastroenterological Surgery, Nagoya City University, Nagoya 464-8681, Japan 4: Department of Microbiology, Kinki University, Graduate School of Medical Sciences, Osaka 589-8511, Japan 5: Colorectal Surgery Division, National Cancer Center Hospital, Tokyo 104-0045, Japan 6: Department of Pathology and Molecular Medicine, Aichi Cancer Center Central Hospital, Nagoya 464-8681, Japan 7: Laboratory of Pathology and Clinical Research, Aichi Cancer Center Aichi Hospital, Okazaki 444-0011, Japan
Publication date: 01 January 2014
- The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content